中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
Announcement of the New Version of the Instruction Manual for Ruyi Zhenbao Tablets
2024-03-16
Tibetan medicinal wisdom shines across the globe—health and the New Year go hand in hand.
2024-02-11
Qizheng Tibetan Medicine and its subsidiaries have once again been recognized as “National High-Tech Enterprises.”
2024-01-19
ESG Practices Enhance Brand Reputation: Qizheng Tibetan Medicine Wins the ECI International Digital Economy Innovation Award
2023-12-11
Qizheng Tibetan Medicine Listed Among the “Top 20 Chinese Medicine Enterprises with the Greatest International Influence”
2023-11-02
Qizheng Tibetan Medicine (002287) has been selected as a Best Practice Case in Corporate Governance for 2023 by the China Association of Listed Companies.
Qizheng Public Welfare launches the Pain Relief Care Initiative in Mainland China, reaching 37 cities nationwide.
2023-10-17
Tibetan medicine has once again earned a world-class honor—the “Four Medical Tantras” have been inscribed on the UNESCO Memory of the World Register.
2023-10-12
Qizheng Tibetan Medicine joins hands with Migu Video to invite you to watch the exciting events together!
2023-09-23
The Key to High-Quality Development of Tibetan Medicine: Building and Applying a Modern Research Model for Tibetan Medicines Under the Guidance of Tibetan Medical Theory
2023-09-21
Pioneering a New Chapter in Omnichannel Marketing for Multiple Products: Qizheng Tibetan Medicine Sees 34.41% Growth in Net Profit for the First Half of the Year
2023-08-25
Qizheng Tibetan Medicine’s net profit for the first half of 2023 increased by 34.41% year-on-year.
Qizheng Tibetan Medicine ranked 29th on the “2022 China Top 100 Chinese Materia Medica Enterprises List.”
2023-06-28
Qizheng Tibetan Medicine Wins the “14th China Listed Companies Investor Relations New Media Award”
2023-05-26
Qizheng Tibetan Medicine Wins Two Major Awards: the “Panoramic Investor Relations Gold Award (2022)”
2023-05-25